Phase 1 study to assess safety, tolerability, biodistribution, radiation and dosimetry of [18F]FPyGal, a recently developed PET tracer for the non-invasive assessment of cellular senescence

MLA

Wäschle, A., et al. “Phase 1 Study to Assess Safety, Tolerability, Biodistribution, Radiation and Dosimetry of [18F]FPyGal, a Recently Developed PET Tracer for the Non-Invasive Assessment of Cellular Senescence.” Nuklearmedizin. Nuclear Medicine, vol. 63, no. 2, Mar. 2024. EBSCOhost, https://doi.org/10.1055/s-0044-1782319.

APA

Wäschle, A., Kupferschläger, J., Trautwein, N., Dittmann, H., Schwenck, J., Pritzkow, M., Gückel, B., Cotton, J., Reischl, G., Zender, L., Pichler, B., & la Fougère, C. (2024). Phase 1 study to assess safety, tolerability, biodistribution, radiation and dosimetry of [18F]FPyGal, a recently developed PET tracer for the non-invasive assessment of cellular senescence. Nuklearmedizin. Nuclear Medicine, 63(2). https://doi.org/10.1055/s-0044-1782319

Chicago

Wäschle, A., J. Kupferschläger, N. Trautwein, H. Dittmann, J. Schwenck, M. Pritzkow, B. Gückel, et al. 2024. “Phase 1 Study to Assess Safety, Tolerability, Biodistribution, Radiation and Dosimetry of [18F]FPyGal, a Recently Developed PET Tracer for the Non-Invasive Assessment of Cellular Senescence.” Nuklearmedizin. Nuclear Medicine 63 (2). doi:10.1055/s-0044-1782319.